Dystroglycan Antikörper (AA 31-140)
Kurzübersicht für Dystroglycan Antikörper (AA 31-140) (ABIN560555)
Target
Alle Dystroglycan (DAG1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 31-140
-
Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant DAG1.
-
Sequenz
- WPSEPSEAVR DWENQLEASM HSVLSDLHEA VPTVVGIPDG TAVVGRSFRV TIPTDLIASS GDIIKVSAAG KEALPSWLHW DSQSHTLEGL PLDTDKGVHY ISVSATRLGA
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- DAG1 (AAH12740, 31 a.a. ~ 140 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
The N-terminal domain of ?-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis." in: Biochemical and biophysical research communications, Vol. 412, Issue 3, pp. 494-9, (2011) (PubMed).
: "
-
The N-terminal domain of ?-dystroglycan, released as a 38 kDa protein, is increased in cerebrospinal fluid in patients with Lyme neuroborreliosis." in: Biochemical and biophysical research communications, Vol. 412, Issue 3, pp. 494-9, (2011) (PubMed).
-
- Dystroglycan (DAG1) (Dystroglycan 1 (DAG1))
-
Andere Bezeichnung
- DAG1
-
Hintergrund
-
Full Gene Name: dystroglycan 1 (dystrophin-associated glycoprotein 1)
Synonyms: 156DAG,A3a,AGRNR,DAG -
Gen-ID
- 1605
-
Pathways
- Maintenance of Protein Location, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus
Target
-